Kantonsspital St.Gallen

MSD MK1308A-004

Roman Stillhard, David Semela & Irina Bergamin

abstract Phase 2, Multicenter, Clinical Study to Evaluate the Safety and Efficacy of
MK-1308A (Coformulated MK-1308/MK-3475) in Combination with Lenvatinib (E7080/MK-7902) in First-line Therapy of Participants with Advanced Hepatocellular Carcinoma
type of project clinical studies
status ongoing - recruiting phase
start of project 2021
end of project 2022
responsible person David Semela